Recap: Panbela Therapeutics Q4 Earnings
Recap: Panbela Therapeutics Q4 Earnings
Panbela Therapeutics (OTC:PBLA) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:10 PM.
Panbela Therapeutics(場外交易代碼:PBLA)於2024年3月26日星期二下午4點10分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Panbela Therapeutics missed estimated earnings by -171.0%, reporting an EPS of $-65.9 versus an estimate of $-24.34.
Panbela Therapeutics報告每股收益爲-65.9美元,未達到預期收益-171.0%,而預期爲-24.34美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company missed on EPS by $0.36 which was followed by a 3.0% increase in the share price the next day.
上個季度,該公司的每股收益未達到0.36美元,隨後第二天股價上漲了3.0%。
To track all earnings releases for Panbela Therapeutics visit their earnings calendar here.
要追蹤Panbela Therapeutics發佈的所有業績,請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。